Acting upon evidence: Progress towards the elimination of unsafe injection practices in India

Indian Pediatrics

Volumn 42, Issue 2, 2005, Pages 111-115

  Hutin, Yvan J F ^a,b,c  

^a Safe Injection Global Network (SIGN)   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHRONIC LIVER DISEASE; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH HAZARD; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INDIA; INJECTION; INSTRUMENT STERILIZATION; NEEDLESTICK INJURY; PEDIATRICIAN; PRESCRIPTION; RISK ASSESSMENT; SAFETY; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

CHILD; HUMANS; INDIA; INJECTIONS; PUBLIC HEALTH; SAFETY;

EID: 14744279543     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. Hutin YJF, Hauri AM, Armstrong GL. Overuse and unsafe use of injections worldwide: Literature review and regional estimates. BMJ 2003; 327: 1075-1078.
2. Hauri AM, Armstrong GL, Hutin YJF. The Global Burden of Disease Attributable to Contaminated Injections Given in Health Care Settings. Int J STD AIDS 2004; 15: 7-16.
3. Hutin Y, Hauri A, Chiarello L, Catlin M, Stilwell B, Ghebrehiwet T, Garner J and the Members of the Injection Safety Best Practices Development Group. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ 2003; 81: 491-500.
4. WHO. Injection safety: Guiding principles to ensure injection device security. 10 September 2003. WHO/BCT/03.12. Available at www. injectionsafety.org
5. "Aide Memoire" for safe health care waste management. WHO department of the Protection of Human Environment, November 2000. Available at www.injectionsafety:org
6. Dziekan G, Chisholm D, Johns B, Rovira J, Hutin YJF. The cost-effectiveness of policies for the safe and appropriate use of injection in health care settings. Bull World Health Organ 2003; 81: 277-285.
7. Lakshman M, Nichter M. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study. Soc Sci Med 2000; 51: 11-28.
8. Anand K, Pandav CS, Kapoor SK. Injection use in a village in North India. Nat Med J India 2001; 14: 143-144.
9. Narendranathan M, Philip M. Reusable needles-a major risk factor for acute virus B hepatitis. Tropical Doctor 1993; 23: 64-66.
10. Singh J, Bhatia R, Patnaik SK, et al. Community studies on hepatitis B in Rajahmundry town of Andra Pradesh, India, 1997-1998: unnecessary therapeutic injections are a major risk factor. Epidemiol Infect 2000; 125: 367-375.
11. WHO: Safe Injection Global Network: Annual meeting report. 30-31 August 2001 (New Delhi, India). WHO/BCT/DCT/01.04, WHO, Geneva, 2001. Available at www.injectionsafety.org
12. Krishna M. The India injection safety coalition. In: Safe Injection Global Network: Annual meeting report. 24-25 October 2002. p. 14. (Phnom Penh, Cambodia). WHO/BCT/ 02.13, WHO, Geneva, 2002. Available at www.injectionsafety. org
13. The WMA statement on safe injections in health care. Initiated on October 2001. MECV SafeInject/Oct2002. World Medical Association, Ferney Voltaire, France. Available at www.wma.net
14. Indian Medical Association. Policy on Safe Injections in Health Care Settings: 'Safe Injections Safe Life'. Accessible on-line at http://www.imanational.com/Projects1.asp.
15. Craig WA, Andes DR. Parenteral versus oral antibiotic therapy. Antimicrobial therapy 1995; 79: 497-508.
16. Bannwarth B, Netter P, Giroud JP. Intravenous use of NSAIDs. In "Therapeutic applications of NSAIDs. Subpopulations and new formulations." Edited by J P Famaey and H.E Paulus. Marcel Dekker Inc., New York, Basel, Hong Kong, pp. 413-422.
17. Prawitasari Hadiyono JE, Suryawati S, Danu SS, Sunartono, Santoso B. Interactional group discussion: Results of a controlled trial using a behavioural intervention to reduce the use of injections in public health facilities. Soc Sci Med 1996; 42: 1177-1183.
18. Centers for Disease Control and Prevention. Frequency of vaccine-related and therapeutic injection - Romania 1998. MMWR 1999; 48: 271-274.
19. Logez S, Soyolgerel G, Fields R, Luby S, Hutin Y. Rapid Assessment of Injection Practices in Mongolia. Am J Inf Cont 2004; 32: 31-37.
20. Agboatwalla M, Hutin Y, Luby S, Mussarat A. A pilot intervention to improve injection practices in the informal private sector in Karachi, Pakistan. Presentation given at the second International Conference on Improving Use of Medicines (ICIUM), Chiang Mai, Thailand, 30 March-2 April 2004, abstract #AC 112.
21. Massele A, Nsimba S, Kayombo E, Mugoyela V. Reducing injection overuse through interactive group discussion with patients and prescribers at primary care facilities in Dar el Salaam, Tanzania. Presentation given at the second International Conference on Improving Use of Medicines (ICIUM), Chiang Mai, Thailand, 30 March-2 April 2004, abstract #AD 025.
22. Chean Men. Interactive Group Discussion: An intervention to reduce the overuse of injections at public health care facilities in Cambodia. Presentation given at the second International Conference on Improving Use of Medicines (ICIUM), Chiang Mai, Thailand, 30 March-2 April 2004, abstract #AC051.
23. Recommendations. IAP Workshop on Safe Injection Practices: Recommendations and IAP Plan of Action. Indian Pediatr 2005; 42: 155-161.